
Effects of M1 microglia-derived exosomes on the function of the blood-brain barrier
Jiang Wen, Deng Qionghua, Mei Song
Effects of M1 microglia-derived exosomes on the function of the blood-brain barrier
Objective To investigate the effects of M1 microglia-derived exosomes(M1-exo) on the function of an in-vitro blood-brain barrier(BBB) model and the expression of tight junction proteins between vascular endothelial cells. Methods Mouse microglia-derived BV2 cells were stimulated with lipopolysaccharide to be polarized towards the M1 phenotype,and exosomes were isolated and extracted after the phenotype was confirmed by flow cytometry. An in-vitro BBB model was constructed using the mouse brain microvascular endothelial cell line b.End3 and primary cultured mouse astrocytes. The BBB model was co-cultured with exosomes of different sources in three groups:normal culture for b.End3 cells(b.End3 group);b.End3 cells + 25 μg/mL exosomes derived from normal BV-2 cells(b.End3+BV2-exo group);and b.End3 cells+25 μg/mL M1-exo(b.End3+M1-exo group). Trans-endothelial electrical resistance(TEER) and Lucifer yellow permeability were examined. The expression of tight junction complex proteins(claudin-1,occludin,zonula occludens-1[ZO-1],and junctional adhesion molecules) was measured by Western blot. Results Microglia were successfully polarized to the M1 type,and the positivity rate of the M1 marker CD16/32 was significantly increased compared with the control group(P=0.023). After co-culture with M1-exo,the TEER of the in-vitro BBB model was significantly decreased(P<0.001),and Lucifer yellow permeability was significantly increased(P<0.001). Compared with the b.End3 group and b.End3+BV2-exo group,the b.End3+M1-exo group showed significantly decreased expression levels of claudin-1,occludin,and ZO-1. Conclusion M1-exo can disrupt the integrity of BBB and interfere with its normal function.
M1 microglia / exosome / in-vitro blood-brain barrier model / ischemic stroke
1 |
GBD Stroke Collaborators. Global,regional,and national burden of stroke and its risk factors,1990-2019:a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet Neurol,2021,20(10):795-820.
|
2 |
|
3 |
|
4 |
|
5 |
|
6 |
|
7 |
|
8 |
|
9 |
|
10 |
|
11 |
|
12 |
|
13 |
|
14 |
|
15 |
|
16 |
|
17 |
|
18 |
|
19 |
|
20 |
|
21 |
|
/
〈 |
|
〉 |